Medical Research Network Inc.

Medical Research Network Inc. , based in New York, specializes in clinical research services aimed at developing new medical treatments and therapies by facilitating clinical trials across various therapeutic areas. Founded in 1997, MRN engages in clinical research services to enhance patient outcomes. The company has primarily operated in New York, US.

In July 2025, MRN was acquired by The IMA Group, a portfolio company of Centre Partners, although financial terms were not disclosed. This acquisition aims to strengthen and enhance research and clinical operations. Medical Research Network, LLC specializes in clinical research services focused on advancing the development of new medical treatments and therapies. The company conducts trials that explore innovative solutions in various therapeutic areas, aiming to enhance patient outcomes and address unmet medical needs.

Their programs often target conditions related to mental health, indicating a focus on improving treatment options for patients experiencing psychological disorders. The company engages with a diverse clientele, including pharmaceutical companies, biotechnology firms, and healthcare providers, facilitating access to research for new medications and therapies, primarily within urban markets across the United States. The revenue model of Medical Research Network, LLC is structured around direct partnerships with pharmaceutical and biotechnology companies that sponsor clinical trials. Each trial typically involves a contractual agreement where the sponsors provide funding in exchange for research and data on the efficacy of their products.

Transactions within this framework often follow a service fee structure, ensuring a consistent revenue stream tied to the successful execution of clinical trials. Specific pricing arrangements for these services are determined through individual agreements based on the scope and complexity of each trial. Following its acquisition by The IMA Group in July 2025, Medical Research Network (MRN) plans to enhance its research and clinical operations. The strategic focus will include the development of new clinical trials aimed at diverse therapeutic areas, improving mental health treatment options, and expanding its geographic footprint into additional urban markets in the US.

The recent funding will support these initiatives, ensuring that MRN can further its mission of delivering innovative medical solutions.